A analyze revealed in JAMA Community Open up emphasizes the discrepancy between what it expenses to supply copyright plus the retail rates people experience. Regardless of the low manufacturing costs, Novo Nordisk hasn't publicly disclosed particular figures for copyright or its other products, Wegovy.inflammation of one's pancreas (pancreatitis).